🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
565,72 USD
Máx. histórico
608,49
1 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,03%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-7,03%
Cierre anterior
608,49
Rango de hoy
561,24 – 608,04
Volumen hoy
602.001
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,36 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 10 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 07/04/2005 | 22,57 | 23,70 | 22,38 | 23,15 | +2,59% | 5,87% | 1.300.800 |
| 06/04/2005 | 22,60 | 22,74 | 22,36 | 22,57 | +0,24% | 1,70% | 486.600 |
| 05/04/2005 | 22,09 | 22,65 | 22,02 | 22,51 | +1,83% | 2,88% | 446.600 |
| 04/04/2005 | 22,60 | 22,60 | 21,92 | 22,11 | -2,04% | 2,99% | 524.800 |
| 01/04/2005 | 22,85 | 22,88 | 22,05 | 22,57 | -1,25% | 3,63% | 1.054.400 |
| 31/03/2005 | 22,41 | 23,06 | 22,30 | 22,85 | +1,87% | 3,39% | 1.060.400 |
| 30/03/2005 | 22,34 | 22,54 | 22,08 | 22,43 | +0,65% | 2,06% | 657.200 |
| 29/03/2005 | 22,14 | 22,68 | 22,01 | 22,29 | +0,38% | 3,03% | 1.359.800 |
| 28/03/2005 | 22,08 | 22,23 | 22,01 | 22,20 | +0,79% | 1,00% | 754.600 |
| 24/03/2005 | 21,87 | 22,48 | 21,87 | 22,03 | +0,20% | 2,77% | 807.600 |
| 23/03/2005 | 21,30 | 22,13 | 21,30 | 21,98 | +2,02% | 3,87% | 628.400 |
| 22/03/2005 | 21,59 | 22,22 | 21,54 | 21,55 | -0,16% | 3,13% | 708.400 |
| 21/03/2005 | 21,50 | 21,63 | 21,44 | 21,58 | +0,72% | 0,88% | 427.600 |
| 18/03/2005 | 21,64 | 21,69 | 21,12 | 21,43 | -0,65% | 2,66% | 960.800 |
| 17/03/2005 | 21,43 | 21,68 | 21,32 | 21,57 | +0,14% | 1,68% | 503.800 |
| 16/03/2005 | 21,52 | 21,84 | 21,44 | 21,54 | -0,30% | 1,88% | 493.200 |
| 15/03/2005 | 21,78 | 22,11 | 21,49 | 21,60 | -0,44% | 2,87% | 666.800 |
| 14/03/2005 | 21,32 | 21,79 | 21,17 | 21,70 | +2,24% | 2,91% | 673.600 |
| 11/03/2005 | 21,55 | 21,66 | 21,15 | 21,22 | -1,92% | 2,37% | 764.600 |
| 10/03/2005 | 22,09 | 22,18 | 21,48 | 21,64 | -2,04% | 3,17% | 715.800 |
| 09/03/2005 | 22,01 | 22,22 | 21,80 | 22,09 | -0,32% | 1,93% | 998.600 |
| 08/03/2005 | 21,93 | 22,23 | 21,93 | 22,16 | +0,96% | 1,39% | 803.200 |
| 07/03/2005 | 21,70 | 22,05 | 21,70 | 21,95 | +0,92% | 1,64% | 573.800 |
| 04/03/2005 | 21,99 | 22,08 | 21,41 | 21,75 | -1,05% | 3,05% | 1.100.400 |
| 03/03/2005 | 22,44 | 22,53 | 21,88 | 21,98 | -2,16% | 2,87% | 625.000 |
| 02/03/2005 | 22,40 | 22,80 | 22,37 | 22,46 | +0,29% | 1,92% | 495.200 |
| 01/03/2005 | 22,69 | 22,85 | 22,29 | 22,40 | -1,41% | 2,49% | 603.800 |
| 28/02/2005 | 22,90 | 22,90 | 22,37 | 22,72 | -0,55% | 2,31% | 455.200 |
| 25/02/2005 | 22,73 | 22,95 | 22,40 | 22,84 | +0,59% | 2,40% | 274.200 |
| 24/02/2005 | 22,35 | 22,71 | 22,06 | 22,71 | +1,61% | 2,91% | 496.800 |